Literature DB >> 9698555

Molecular interactions between the coactivator CBP and the human T-cell leukemia virus Tax protein.

J P Yan1, J E Garrus, H A Giebler, L A Stargell, J K Nyborg.   

Abstract

The oncoprotein Tax, encoded by the human T-cell leukemia virus type I (HTLV-I), is required for high-level viral transcription and is strongly linked to HTLV-I-associated malignant transformation. Recent evidence suggests that Tax stimulates HTLV-I transcription through recruitment of the cellular coactivator protein CBP to the HTLV-I promoter, promoting high-level viral replication via the transcriptional activation properties associated with CBP. Tax directly contacts the KIX domain of CBP to stably anchor the coactivator to nucleoprotein complexes at the promoter. Here, we identify KIX amino acid residues 588 to 683 as the minimal region sufficient for interaction with Tax. This region is similar to the minimal KIX amino acid residues necessary for strong interaction with phosphorylated CREB, and is composed of a structural domain that forms an extensive hydrophobic core. We further show that a double point mutation in KIX differentially affects the binding of Tax and phosphorylated CREB, suggesting that these transcription factors may recognize unique amino acid residues within the KIX domain. These observations suggest that Tax directly contacts the hydrophobic core of KIX, and provides a structural framework to further define the molecular interactions between Tax and CBP. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9698555     DOI: 10.1006/jmbi.1998.1951

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  24 in total

1.  The oncoprotein Tax binds the SRC-1-interacting domain of CBP/p300 to mediate transcriptional activation.

Authors:  K E Scoggin; A Ulloa; J K Nyborg
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  Human T-lymphotropic virus type 1 Tax protein complexes with P-TEFb and competes for Brd4 and 7SK snRNP/HEXIM1 binding.

Authors:  Won-Kyung Cho; Moon Kyoo Jang; Keven Huang; Cynthia A Pise-Masison; John N Brady
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

Review 3.  Insight into the tumor suppressor function of CBP through the viral oncoprotein tax.

Authors:  K Van Orden; J K Nyborg
Journal:  Gene Expr       Date:  2000

4.  Immortalization of T lymphocytes by human T-cell leukemia virus type 1 is independent of the tax-CBP/p300 interaction.

Authors:  M D Robek; L Ratner
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Molecular recognition of protein surfaces: high affinity ligands for the CBP KIX domain.

Authors:  Stacey E Rutledge; Heather M Volkman; Alanna Schepartz
Journal:  J Am Chem Soc       Date:  2003-11-26       Impact factor: 15.419

6.  HTLV-1 HBZ protein deregulates interactions between cellular factors and the KIX domain of p300/CBP.

Authors:  Pamela R Cook; Nicholas Polakowski; Isabelle Lemasson
Journal:  J Mol Biol       Date:  2011-04-08       Impact factor: 5.469

7.  The human T-cell leukemia virus type 1 tax protein confers CBP/p300 recruitment and transcriptional activation properties to phosphorylated CREB.

Authors:  Timothy R Geiger; Neelam Sharma; Young-Mi Kim; Jennifer K Nyborg
Journal:  Mol Cell Biol       Date:  2007-12-10       Impact factor: 4.272

8.  Upregulation of human T-cell leukemia virus type 1 antisense transcription by the viral tax protein.

Authors:  Sébastien Landry; Marilène Halin; Amandine Vargas; Isabelle Lemasson; Jean-Michel Mesnard; Benoit Barbeau
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

Review 9.  Viruses associated with human cancer.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Biochim Biophys Acta       Date:  2007-12-23

10.  Tax recruitment of CBP/p300, via the KIX domain, reveals a potent requirement for acetyltransferase activity that is chromatin dependent and histone tail independent.

Authors:  Sara A Georges; Holli A Giebler; Philip A Cole; Karolin Luger; Paul J Laybourn; Jennifer K Nyborg
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.